The effect of Glucerna^®-EX on glycemic control in head and neck reconstructive operation

Abstract

We used Glucerna^®-EX (low glucide, low GI·GL (glycemic index·glycemic load) for perioperative care after head and neck reconstruction and examined the utility of glycemic control.
The rear watched 79 cases (the Glucerna^®-EX group included 34 cases and the other enteral feeding group included 45 cases) whose histories from August 1, 2008 to December 31, 2011 did not have diabetes, and the subject parsed a mark.
Regarding the mean highest blood glucose level, blood glucose standard deviation, and blood glucose band, the Glucerna^®-EX group showed significantly low levels.
There was no hypoglycemia, more G2 diarrhea and little insulin consumption, so it was considered that glycemic control can be safely and easily carried out in the perioperative period.